Market Place
Sourcing Support
All News #Library
Biotech
Ayrmid Reports Promising New Real-World Data on Motixafortide
06 Dec 2025 //
PHARMIWEB
Gamida Cell Reports Positive Results for Omidubicel in SAA
28 Oct 2025 //
BUSINESSWIRE
BioLineRx & Ayrmid License Agreement for APHEXDA Commercialization
21 Nov 2024 //
PR NEWSWIRE
Gamida Cell Presents Data on Allogeneic Stem Cell Therapy Omidubicel and GDA-201
04 Nov 2023 //
GLOBENEWSWIRE
Gamida Cell Reports Preliminary Data from Phase 1 Study of GDA-201
16 Oct 2023 //
BUSINESSWIRE
First Patient Receives Gamida Cell`s Omisirge™ (omidubicel-onlv)
27 Sep 2023 //
BUSINESSWIRE
Data To Be Presented on Gamida Cell NK Cell Therapy Candidate GDA-201
31 May 2023 //
BUSINESSWIRE
FDA clears Gamida`s allogeneic cell therapy Omisirge
18 Apr 2023 //
FDA
Gamida Cell’s Allogeneic Cell Therapy Omisirge® Receives FDA Approval
17 Apr 2023 //
BUSINESSWIRE
Gamida lays off 17%, ditches NKs to keep omidubicel going
28 Mar 2023 //
FIERCE BIOTECH
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings
18 Feb 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.